All patients | Age group, year | |||||
---|---|---|---|---|---|---|
Women (n=3574) Per cent | Men (n=8412) | <60 (n=3914) | 60–69 (n=3213) OR* | 70–79 (n=3562) | ≥80 (n=1297) | |
Acute medications | ||||||
Aspirin≤24 h | 83.9 | 87.5 | 0.83 | 0.75† | 0.90 | 0.90 |
Clopidogrel≤24 h | 51.5 | 56.6 | 0.80† | 0.81† | 0.86† | 1.01 |
β-Blocker≤24 h | 43.8 | 48.5 | 0.87 | 0.84† | 1.06 | 0.98 |
ACE-I/ARB‡ | 60.2 | 63.8 | 0.90 | 0.88 | 0.90 | 0.73† |
Statin‡ | 73.0 | 75.2 | 0.79† | 0.85† | 1.02 | 1.02 |
Reperfusion therapies ≤24 h | ||||||
Primary PCI | 8.5 | 12.8 | 0.54† | 0.85 | 0.81 | 0.76 |
Fibrinolytic therapy | 18.9 | 24.7 | 0.88 | 0.88 | 0.87 | 1.00 |
Any reperfusion | 27.4 | 37.5 | 0.68† | 0.84† | 0.82† | 0.86 |
Staged procedures | ||||||
Cardiac catheterisation | 18.8 | 28.8 | 0.72† | 0.68† | 0.71† | 0.64† |
PCI | 8.6 | 13.9 | 0.84 | 0.67† | 0.66† | 0.59 |
CABG | 0.34 | 0.61 | 0.58 | 0.41 | 1.02 | – |
Any revascularisation | 8.9 | 14.4 | 0.84 | 0.64† | 0.67† | 0.59 |
Testing | ||||||
Troponin | 48.9 | 49.9 | 0.85 | 0.90 | 0.96 | 1.06 |
Echocardiogram | 46.1 | 52.6 | 0.97 | 0.67† | 0.90 | 0.93 |
In-hospital outcomes | ||||||
Death‡ | 12.5 | 6.7 | 2.29† | 2.21† | 1.20 | 1.38 |
Death‡ + withdrawal from treatment | 17.2 | 9.1 | 2.20† | 2.21† | 1.37† | 1.25 |
Death within 24h | 5.5 | 2.9 | 1.75 | 2.21† | 1.34 | 1.89† |
Composite complications | 15.3 | 11.8 | 1.46† | 1.21 | 1.17 | 1.29 |
Major bleeding | 0.8 | 1.0 | 0.22 | 0.74 | 1.07 | 0.44 |
Length of stay (days) | ||||||
<8 | 29.5 | 22.7 | 1.03 | 0.73† | 1.07 | 1.21† |
8–11 | 20.9 | 24.0 | 1.35† | 0.87 | 0.89 | 0.96 |
12–15 | 21.4 | 23.4 | 1.22† | 1.06 | 0.87 | 0.88 |
≥16 | 28.2 | 29.8 | 1.60† | 0.83 | 1.07 | 0.62† |
*The OR is for the comparison of women with men.
†The OR is significant between women and men.
‡During hospitalisation.
ACE-I/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; Composite complication: recurrent MI, cardiac shock, cardiac arrest, congestive heart failure and ischaemic stroke; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention.